111 related articles for article (PubMed ID: 8200853)
1. A novel antitumor antibiotic, KW-2189 is activated by carboxyl esterase and induces DNA strand breaks in human small cell lung cancer cells.
Ogasawara H; Nishio K; Takeda Y; Ohmori T; Kubota N; Funayama Y; Ohira T; Kuraishi Y; Isogai Y; Saijo N
Jpn J Cancer Res; 1994 Apr; 85(4):418-25. PubMed ID: 8200853
[TBL] [Abstract][Full Text] [Related]
2. Intracellular carboxyl esterase activity is a determinant of cellular sensitivity to the antineoplastic agent KW-2189 in cell lines resistant to cisplatin and CPT-11.
Ogasawara H; Nishio K; Kanzawa F; Lee YS; Funayama Y; Ohira T; Kuraishi Y; Isogai Y; Saijo N
Jpn J Cancer Res; 1995 Jan; 86(1):124-9. PubMed ID: 7737904
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.
Kobayashi E; Okamoto A; Asada M; Okabe M; Nagamura S; Asai A; Saito H; Gomi K; Hirata T
Cancer Res; 1994 May; 54(9):2404-10. PubMed ID: 8162588
[TBL] [Abstract][Full Text] [Related]
4. In vitro enhancement of antitumor activity of a water-soluble duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cells.
Ogasawara H; Nishio K; Ishida T; Arioka H; Fukuoka K; Saijo N
Jpn J Cancer Res; 1997 Nov; 88(11):1033-7. PubMed ID: 9439677
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of duocarmycin A and its novel derivative DU-86 on DNA strand breaks in HeLa S3 cells.
Okamoto A; Asai A; Saito H; Okabe M; Gomi K
Jpn J Cancer Res; 1994 Dec; 85(12):1304-11. PubMed ID: 7852193
[TBL] [Abstract][Full Text] [Related]
6. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
Lee YS; Nishio K; Ogasawara H; Funayama Y; Ohira T; Saijo N
Cancer Res; 1995 Mar; 55(5):1075-9. PubMed ID: 7866991
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of action of quinocarmycin citrate (KW 2152) on mouse L1210 cells in vitro.
Kanamaru R; Konishi Y; Ishioka C; Kakuta H; Sato T; Ishikawa A; Asamura M; Wakui A
Cancer Chemother Pharmacol; 1988; 22(3):197-200. PubMed ID: 3409454
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of duocarmycin derivatives: modification at C-8 position of A-ring pyrrole compounds bearing the simplified DNA-binding groups.
Amishiro N; Nagamura S; Murakata C; Okamoto A; Kobayashi E; Asada M; Gomi K; Tamaoki T; Okabe M; Yamaguchi N; Yamaguchi K; Saito H
Bioorg Med Chem; 2000 Feb; 8(2):381-91. PubMed ID: 10722161
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen peroxide degradation and selective carbidopa-induced cytotoxicity against human tumor lines.
Gilbert JA; Frederick LM; Pobst LJ; Ames MM
Biochem Pharmacol; 2005 Apr; 69(8):1159-66. PubMed ID: 15794936
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
[TBL] [Abstract][Full Text] [Related]
11. Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells.
Sadava D; Phillips T; Lin C; Kane SE
Cancer Lett; 2002 May; 179(2):151-6. PubMed ID: 11888669
[TBL] [Abstract][Full Text] [Related]
12. Induction of IL-8 and monoclyte chemoattractant protein-1 by doxorubicin in human small cell lung carcinoma cells.
Shibakura M; Niiya K; Kiguchi T; Kitajima I; Niiya M; Asaumi N; Huh NH; Nakata Y; Harada M; Tanimoto M
Int J Cancer; 2003 Jan; 103(3):380-6. PubMed ID: 12471621
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
Kalemkerian GP; Slusher R; Ramalingam S; Gadgeel S; Mabry M
J Natl Cancer Inst; 1995 Nov; 87(22):1674-80. PubMed ID: 7473815
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage.
Jensen PB; Sørensen BS; Demant EJ; Sehested M; Jensen PS; Vindeløv L; Hansen HH
Cancer Res; 1990 Jun; 50(11):3311-6. PubMed ID: 2159380
[TBL] [Abstract][Full Text] [Related]
15. Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin.
Lau DH; Durán GE; Sikic BI
J Natl Cancer Inst; 1992 Oct; 84(20):1587-92. PubMed ID: 1404452
[TBL] [Abstract][Full Text] [Related]
16. Contaminants of PC-SPES are not responsible for cytotoxicity in human small-cell lung carcinoma cells.
Sadava D; Winesburg J
Cancer Lett; 2005 Apr; 220(2):171-5. PubMed ID: 15766592
[TBL] [Abstract][Full Text] [Related]
17. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
[TBL] [Abstract][Full Text] [Related]
18. Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification.
Kalemkerian GP; Ou X; Adil MR; Rosati R; Khoulani MM; Madan SK; Pettit GR
Cancer Chemother Pharmacol; 1999; 43(6):507-15. PubMed ID: 10321512
[TBL] [Abstract][Full Text] [Related]
19. Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells.
Sadava D; Ahn J; Zhan M; Pang ML; Ding J; Kane SE
Cancer Chemother Pharmacol; 2002 Apr; 49(4):261-6. PubMed ID: 11914903
[TBL] [Abstract][Full Text] [Related]
20. KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl] mitomycin C): DNA interactions and drug uptake following serum activation.
McAdam SR; Knox RJ; Hartley JA; Masters JR
Biochem Pharmacol; 1998 Jun; 55(11):1777-83. PubMed ID: 9714295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
